Intracavernous sodium nitroprusside: inappropriate impotence treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8345601.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
On the basis of reports describing nitric oxide as a form of endothelium-derived relaxing factor and on our own experience with intracavernous use of nitric oxide-releasing substances in animal models, we undertook an approved human study of intracavernous sodium nitroprusside as a treatment for impotence. We report our early experience in which severe hypotension and only mild tumescence in our first 3 patients caused us to discontinue the trial.
Medical subject headings
- Erectile Dysfunction
- Nitroprusside